In the SUSTAIN-6 trial, injectable semaglutide demonstrated a notable effect in reducing the incidence of nonfatal stroke (hazard ratio [HR] 0.61
It is important to note that whilst these findings are promising, there is no official consensus on GLP-1 receptor agonists being prescribed specifically as anti-inflammatory agents
While some claims were dismissed or excluded from the MDL, most will continue under the consolidated litigation framework
Back Deacon, DF, Johnsen, AH, Holst, JJ (March 1995) 'Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo', Journal Clinical Endocrinology Metabolism , 80/3, 952-7
Q., Long Y., Wang L., Li Y., Gao F
While there are no mandates for ACA plans, many currently offer coverage for approved medications like Zepbound